Author Search Results

1

Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers

by Berthele, A., Diehl-Schmid, J., Goldhardt, O., Grimmer, T., Ortner, M., Priller, J., Zebhauser, P.T
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
2

The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort

by Amft, M., Diehl-Schmid, J., Eichenlaub, U., Goldhardt, O., Grimmer, T., Hedderich, D.M, Ortner, M., Yakushev, I.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
3

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex

by Mehrabian S, Alexopoulos P, Ortner M, Traykov L, Grimmer T, Kurz A, Förstl H, Bickel H, Diehl-Schmid J
Published 2015-12-01

Get full text

Article
4

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil

by Ortner M, Stange M, Schneider H, Schröder C, Buerger K, Müller C, Müller-Sarnowski F, Diehl-Schmid J, Förstl H, Grimmer T, Steimer W
Published 2020-08-01

Get full text

Article
5

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography

by Ortner M, Hauser C, Schmaderer C, Muggenthaler C, Hapfelmeier A, Sorg C, Diehl-Schmid J, Kurz A, Förstl H, Ikenberg B, Kotliar K, Poppert H, Grimmer T
Published 2019-12-01

Get full text

Article